Further analysis performed on the metabolic network (Figure 4E) to understand the interaction between different metabolites showed that CASR in the CHD treatment mainly regulated the sphingolipid metabolism, glycerophospholipid metabolism, and glycerolipid metabolism. The gene discussed is CASR; the disease is coronary artery disorder.